SCHEMBL4155045

SCHEMBL4155045

CC(C)(C)c1ccc(CC(C(N)=O)c2ccc(O[Si](C)(C)C)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 8/20 0.44
GCGR P47871 3/20 0.41
ADCY6 O43306 2/20 0.41
ADCY3 O60266 2/20 0.41
ADCY9 O60503 2/20 0.41
ADCY5 O95622 2/20 0.41
ADCY8 P40145 2/20 0.41
ADCY7 P51828 2/20 0.41
ADCY2 Q08462 2/20 0.41
ADCY1 Q08828 2/20 0.41
ADCY4 Q8NFM4 2/20 0.41
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
NR4A2 P43354 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4152962 0.86 MEN1 (0.51) EPHX1GCGRADCY6ADCY3ADCY9
SCHEMBL5188913 0.82 EPHX1 (0.44) EPHX1GCGRADCY6ADCY3ADCY9
SCHEMBL4027743 0.81 ESR1 (0.58) EPHX1ESR1ESR2
SCHEMBL3271868 0.81 EPHX1 (0.51) EPHX1GCGRADCY6ADCY3ADCY9
SCHEMBL5176814 0.80 EPHX1 (0.50) EPHX1GCGRADCY6ADCY3ADCY9
SCHEMBL5175289 0.80 EPHX1 (0.50) EPHX1GCGRADCY6ADCY3ADCY9
SCHEMBL3273907 0.80 EPHX1 (0.50) EPHX1GCGRADCY6ADCY3ADCY9
SCHEMBL3942501 0.80 EPHX1 (0.50) EPHX1GCGRADCY6ADCY3ADCY9
Hydrochloric Acid SCHEMBL4026086 0.79 EPHX1 (0.49) EPHX1GCGRADCY6ADCY3ADCY9
SCHEMBL4034059 0.77 MEN1 (0.44) EPHX1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090171091-A1 COMPOUNDS SUITABLE AS MODULATORS OF HDL CADILA HEALTHCARE LIMITED (IN) 2009-07-02 US claimed
US-20090171091-A1 COMPOUNDS SUITABLE AS MODULATORS OF HDL CADILA HEALTHCARE LIMITED (IN) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090171091-A1 COMPOUNDS SUITABLE AS MODULATORS OF HDL CETP, APOB, HDLBP EPHX1 1260/4885GCGR 291/4885ADCY6 1555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.